The Hindu Business Line : GSK Pharma India MD to oversee Lanka, Bangladesh

THE Managing Director of GlaxoSmithKline Pharmaceuticals (GSK) in India, Mr S. Kalyanasundaram, has been given additional charge of Bangladesh and Sri Lanka with immediate effect.

According to an official communiqué, the company's General Managers in Bangladesh and Sri Lanka will now report to Mr Kalyanasundaram, who will continue to be based in Mumbai.

Mr V. Thyagarajan, Senior Vice-President and Area Director, Asia Pacific, said: "The three South Asian markets present exciting opportunities for business development and the future introduction of innovative and speciality medicine following the re-introduction of product patent protection in India in 2005."

Mr Kalyanasundaram was appointed as Managing Director in India on January 1, 2003.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Lupin plans 3-fold hike in research spend

GSK Pharma India MD to oversee Lanka, Bangladesh

Biocon insulin likely to be in market soon

ICI to invest Rs 800 cr for acquisition, expansion

Apollo moots pvt placement

Standard soon on `employee share-based payments': ICAI

Manu Chhabria's mother stakes claim to estate

M.P. Birla's sisters file caveats

Concept paper for slimmer Companies Act finalised

Hindalco shareholders' no to Lodha & Co

Torrent Pharma, Novartis tie up

HLL looks at `long term'; unfazed by Q2 nos

ITC looks to emerge on top in paper, hotel biz